Wharton's jelly derived mesenchymal stem cell

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
90	網膜色素変性症	1

90. 網膜色素変性症

臨床試験数 : 147 / 薬物数 : 176 - (DrugBank : 43) / 標的遺伝子数 : 49 - 標的パスウェイ数 : 110

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04224207 (ClinicalTrials.gov)	April 1, 2019	6/1/2020	Management of Retinitis Pigmentosa by Mesenchymal Stem Cells by Wharton's Jelly Derived Mesenchymal ...	Management of Retinitis Pigmentosa by Wharton's Jelly Derived Mesenchymal Stem Cells: Preliminary Cl ...	Retinitis Pigmentosa;Inherited Retinal Dystrophy	Biological: Wharton's jelly derived mesenchymal stem cell	Ankara Universitesi Teknokent	NULL	Completed	18 Years	60 Years	All	32	Phase 3	Turkey

First Previous1Next Last